Literature DB >> 31160758

The selective retinoic acid receptor-α agonist AM580 fails to control autoimmune neuroinflammation.

Qing Wang1,2, Rodolfo Thome1, Abdolmohamad Rostami1, Cun-Gen Ma3, Guang-Xian Zhang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31160758      PMCID： PMC6804666          DOI： 10.1038/s41423-019-0238-9

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

1.  The effect of vitamin A supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.

Authors:  Mohammad Hassan Harrirchian; Niyaz Mohammadzadeh Honarvar; Fariba Koohdani; Sama Bitarafan; Fereydoon Siassi; Sima Jafarirad; Mina Abdolahi; Eisa Salehi; Mohammad Ali Saharian; Homa Rouystaee; Mohammad Reza Eshraghian; Ali Akbar Saboor-Yarghi
Journal:  Acta Med Iran       Date:  2014

2.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

Authors:  Kerstin Berer; Marsilius Mues; Michail Koutrolos; Zakeya Al Rasbi; Marina Boziki; Caroline Johner; Hartmut Wekerle; Gurumoorthy Krishnamoorthy
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

Review 3.  Multiple sclerosis.

Authors:  Alan J Thompson; Sergio E Baranzini; Jeroen Geurts; Bernhard Hemmer; Olga Ciccarelli
Journal:  Lancet       Date:  2018-03-23       Impact factor: 79.321

Review 4.  Effector T Cells in Multiple Sclerosis.

Authors:  Belinda J Kaskow; Clare Baecher-Allan
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

5.  Retinoic acid receptors: from molecular mechanisms to cancer therapy.

Authors:  Alessandra di Masi; Loris Leboffe; Elisabetta De Marinis; Francesca Pagano; Laura Cicconi; Cécile Rochette-Egly; Francesco Lo-Coco; Paolo Ascenzi; Clara Nervi
Journal:  Mol Aspects Med       Date:  2014-12-25

6.  Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Christian Klemann; Benjamin J E Raveney; Anna K Klemann; Tomoko Ozawa; Stephan von Hörsten; Koichi Shudo; Shinji Oki; Takashi Yamamura
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

7.  AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.

Authors:  M Gianní; M Li Calzi; M Terao; G Guiso; S Caccia; T Barbui; A Rambaldi; E Garattini
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

8.  Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.

Authors:  M K Racke; D Burnett; S H Pak; P S Albert; B Cannella; C S Raine; D E McFarlin; D E Scott
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

9.  Experimental effect of retinoic acids on apoptosis during the development of diabetic retinopathy.

Authors:  Nami Nishikiori; Makoto Osanai; Hideki Chiba; Takashi Kojima; Shuichiro Inatomi; Hiroshi Ohguro; Norimasa Sawada
Journal:  Clin Ophthalmol       Date:  2008-03

10.  Amyloid β inhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist.

Authors:  Maria B Goncalves; Earl Clarke; Carl Hobbs; Tony Malmqvist; Robert Deacon; Julian Jack; Jonathan P T Corcoran
Journal:  Eur J Neurosci       Date:  2013-02-04       Impact factor: 3.386
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.